pharmaphorum18d
GSK's malaria vaccine gets WHO okay for mass rollout
The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...
FiercePharma14h
With new FDA approval, GSK joins Pfizer in the 5-in-1 meningococcal vaccine ring
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
pharmaphorum6d
GSK and J&J lead in vaccines research – but pricing still an issue
One example of this is GSK’s commitment to make its new malaria vaccine RTS,S affordable, the company planning to price it at £8.50 (10.42 US dollars) per child, based on demand of around 100 ...
Hosted on MSN1mon
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Both of the malaria vaccines prequalified by the World Health Organisation (WHO) and recommended for use in children are pre-erythrocytic. These are GSK’s Mosquirix (recommended since 2021 ...
Vox25d
The frustrating reason we’re not saving more kids from malaria
GlaxoSmithKline (GSK ... It’s not that the Gates Foundation is snubbing malaria vaccines — as one of Gavi’s biggest donors, Gates is helping to fund the R21 rollout. But rather than put ...
FierceBiotech3d
GSK plans to move vaccine R&D group from Maryland to the Boston area
After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...
C&EN2d
Can tiny lab-grown plants solve a big vaccine problem?
The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...
FiercePharma10d
With Blenrep's revival, GSK dials up long-term sales goal—again—despite RSV vaccine woes
Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...
The Boston Globe4d
GSK to grow Massachusetts work force with move from Maryland
Biopharmaceutical company GSK is growing its Massachusetts work force, announcing plans to move its vaccines research and development and infectious disease teams from suburban Maryland to ...
Medscape21d
Plasmodium falciparum Malaria Vaccines in Development
Other FP9 and MVA polyprotein constructs including combination vaccines with CS and LSA1 antigens are being developed at the University of Oxford with the European Malaria Vaccine Initiative (EMVI ...
Yahoo Finance9d
GSK stays optimistic on vaccines amidst US and China woes
GSK blames political and regulatory pressures for the decline in its vaccine’s business in 2024, as it expects sales to further shrink in 2025. Despite these challenges, GSK beat Q4 2024 ...
Medscape16d
Plasmodium falciparum Malaria Vaccines in Development
Expert Rev Vaccines. 2008;7(2):223-240. The EMVI is currently supporting preclinical activities at the Statens Serum Institute in Copenhagen and the Institut Pasteur in Paris for the development ...